BACKGROUND: The Urban Environment and Childhood Asthma study was established to investigate the immunologic and environmental causes of asthma in inner-city children. OBJECTIVE: We sought to evaluate potential atopic outcomes in the first 12 months and their relationships to environmental exposures and immune development. METHODS: A birth cohort of 560 children with at least 1 parent with allergy or asthma was established in Baltimore, Boston, New York, and St Louis. Wheezing is assessed every 3 months, allergen-specific IgE yearly, and mononuclear cell cytokine responses at birth and yearly; environmental assessments include dust allergen and endotoxin, maternal stress, and indoor nicotine and nitrogen dioxide levels. RESULTS: Key outcomes in the first year include wheeze in 49%, 2 or more episodes of wheeze in 23%, eczema in 30%, and detectable IgE to milk, egg, and/or peanut in 32% and to cockroach in 4%. Household dust revealed levels of greater than 2 μg/g to cockroach in 40%, mite in 19%, cat in 25%, and mouse in 29%, and 66% of homes housed at least 1 smoker. Positive associations were detected between multiple wheeze and cotinine levels, maternal stress, and maternal depression, whereas cytokine responses to a variety of innate, adaptive, and mitogenic stimuli were inversely related to eczema. CONCLUSIONS: This high-risk cohort of inner-city infants is exhibiting high rates of wheeze, eczema, and allergic sensitization. Low cytokine responses at birth might be a risk factor for eczema, whereas a variety of adverse environmental exposures contribute to the risk of wheezing in infancy. These findings provide evidence of specificity in the interactions between immune development, environmental exposures, and the development of early features that might predict future asthma.
BACKGROUND: The Urban Environment and Childhood Asthma study was established to investigate the immunologic and environmental causes of asthma in inner-city children. OBJECTIVE: We sought to evaluate potential atopic outcomes in the first 12 months and their relationships to environmental exposures and immune development. METHODS: A birth cohort of 560 children with at least 1 parent with allergy or asthma was established in Baltimore, Boston, New York, and St Louis. Wheezing is assessed every 3 months, allergen-specific IgE yearly, and mononuclear cell cytokine responses at birth and yearly; environmental assessments include dust allergen and endotoxin, maternal stress, and indoor nicotine and nitrogen dioxide levels. RESULTS: Key outcomes in the first year include wheeze in 49%, 2 or more episodes of wheeze in 23%, eczema in 30%, and detectable IgE to milk, egg, and/or peanut in 32% and to cockroach in 4%. Household dust revealed levels of greater than 2 μg/g to cockroach in 40%, mite in 19%, cat in 25%, and mouse in 29%, and 66% of homes housed at least 1 smoker. Positive associations were detected between multiple wheeze and cotinine levels, maternal stress, and maternal depression, whereas cytokine responses to a variety of innate, adaptive, and mitogenic stimuli were inversely related to eczema. CONCLUSIONS: This high-risk cohort of inner-city infants is exhibiting high rates of wheeze, eczema, and allergic sensitization. Low cytokine responses at birth might be a risk factor for eczema, whereas a variety of adverse environmental exposures contribute to the risk of wheezing in infancy. These findings provide evidence of specificity in the interactions between immune development, environmental exposures, and the development of early features that might predict future asthma.
Authors: M M Hagendorens; C H Bridts; K Lauwers; S van Nuijs; D G Ebo; A Vellinga; L S De Clerck; H P Van Bever; J J Weyler; W J Stevens Journal: Clin Exp Allergy Date: 2005-06 Impact factor: 5.018
Authors: Matthew S Perzanowski; Rachel L Miller; Peter S Thorne; R Graham Barr; Adnan Divjan; Beverley J Sheares; Robin S Garfinkel; Frederica P Perera; Inge F Goldstein; Ginger L Chew Journal: J Allergy Clin Immunol Date: 2006-02-14 Impact factor: 10.793
Authors: Wanda Phipatanakul; Juan C Celedón; Diane L Sredl; Scott T Weiss; Diane R Gold Journal: Ann Allergy Asthma Immunol Date: 2005-05 Impact factor: 6.347
Authors: Rebecca S Gruchalla; Jacqueline Pongracic; Marshall Plaut; Richard Evans; Cynthia M Visness; Michelle Walter; Ellen F Crain; Meyer Kattan; Wayne J Morgan; Suzanne Steinbach; James Stout; George Malindzak; Ernestine Smartt; Herman Mitchell Journal: J Allergy Clin Immunol Date: 2005-03 Impact factor: 10.793
Authors: N Kondo; Y Kobayashi; S Shinoda; R Takenaka; T Teramoto; H Kaneko; T Fukao; E Matsui; K Kasahara; Y Yokoyama Journal: Clin Exp Allergy Date: 1998-11 Impact factor: 5.018
Authors: Brock H Medsker; Erick Forno; Yueh-Ying Han; Edna Acosta-Pérez; Angel Colón-Semidey; Maria Alvarez; John F Alcorn; Glorisa J Canino; Juan C Celedón Journal: Ann Allergy Asthma Immunol Date: 2017-07 Impact factor: 6.347
Authors: Jill Hahn; Diane R Gold; Brent A Coull; Marie C McCormick; Patricia W Finn; David L Perkins; Janet W Rich-Edwards; Sheryl L Rifas Shiman; Emily Oken; Laura D Kubzansky Journal: Psychosom Med Date: 2019-05 Impact factor: 4.312
Authors: Wendy F Davidson; Donald Y M Leung; Lisa A Beck; Cecilia M Berin; Mark Boguniewicz; William W Busse; Talal A Chatila; Raif S Geha; James E Gern; Emma Guttman-Yassky; Alan D Irvine; Brian S Kim; Heidi H Kong; Gideon Lack; Kari C Nadeau; Julie Schwaninger; Angela Simpson; Eric L Simpson; Jonathan M Spergel; Alkis Togias; Ulrich Wahn; Robert A Wood; Judith A Woodfolk; Steven F Ziegler; Marshall Plaut Journal: J Allergy Clin Immunol Date: 2019-01-09 Impact factor: 10.793
Authors: Maya Ramagopal; Zuocheng Wang; Kathleen Black; Marta Hernandez; Adam A Stambler; Osiloke H Emoekpere; Gediminas Mainelis; Stuart L Shalat Journal: J Expo Sci Environ Epidemiol Date: 2014-05-07 Impact factor: 5.563
Authors: Marilyn Halonen; I Carla Lohman; Debra A Stern; Whitney L Ellis; Janet Rothers; Anne L Wright Journal: Am J Respir Crit Care Med Date: 2013-07-01 Impact factor: 21.405
Authors: Sima K Ramratnam; Cynthia M Visness; Katy F Jaffee; Gordon R Bloomberg; Meyer Kattan; Megan T Sandel; Robert A Wood; James E Gern; Rosalind J Wright Journal: Am J Respir Crit Care Med Date: 2017-03-01 Impact factor: 21.405